BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2025 Earnings Call Transcript August 4, 2025
BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $1.44, expectations were $1.03.
Operator: Good afternoon. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the BioMarin Pharmaceuticals Second Quarter 2025 Conference Call. Today’s conference is being recorded. [Operator Instructions] At this time, I would like to...
